What is the appropriate antibiotic regimen for a suspected peritonsillar abscess?

Antibiotic Treatment for Peritonsillar Abscess

For suspected peritonsillar abscess, initiate empiric antibiotic therapy with penicillin (penicillin V 500 mg PO four times daily or benzathine penicillin G 1.2 million units IM once) or amoxicillin-clavulanate (875/125 mg PO twice daily), combined with needle aspiration or incision and drainage as the primary intervention.

Primary Treatment Approach

The cornerstone of peritonsillar abscess management is drainage plus antibiotics, not antibiotics alone. Needle aspiration or incision and drainage must be performed alongside antibiotic therapy 1. The abscess will not resolve with antibiotics alone in most cases.

First-Line Antibiotic Regimens

For Patients Without Penicillin Allergy:

Penicillin remains the primary choice because Group A β-hemolytic Streptococcus is the predominant pathogen 2, 3. Options include:

• Penicillin V: 500 mg PO four times daily for 10 days 4
• Amoxicillin: 500 mg PO three times daily for 10 days 4
• Benzathine penicillin G: 1.2 million units IM as a single dose (ensures compliance) 4

Important caveat: While penicillin covers streptococci effectively, approximately 32% of peritonsillar abscesses contain penicillin-resistant organisms, particularly Staphylococcus aureus and anaerobes 5. However, recent high-quality evidence shows no benefit from adding metronidazole to penicillin therapy 6. The 2023 systematic review found that metronidazole addition increased side effects without improving clinical outcomes, recurrence rates, or hospital length of stay.

Alternative First-Line Option:

Amoxicillin-clavulanate (875/125 mg PO twice daily for 10 days) provides broader coverage including β-lactamase-producing organisms and anaerobes 3. This may be preferred in:

• Patients with prior antibiotic exposure
• Severe presentations with systemic toxicity
• Failed initial penicillin therapy

For Penicillin-Allergic Patients:

• Clindamycin: 300-450 mg PO three times daily for 10 days 7, 4

  • Covers both streptococci and anaerobes
  • Effective against most S. aureus (including some MRSA)
  • Warning: Higher risk of Clostridioides difficile infection 7

• Cephalosporins (if no immediate-type hypersensitivity): Cephalexin 500 mg PO twice daily for 10 days 4

When to Escalate Therapy

Indications for Inpatient IV Antibiotics:

Hospitalize and initiate IV therapy for patients with:

• Inability to tolerate oral intake due to trismus or dysphagia
• Signs of systemic toxicity (fever >101°F, tachycardia, hypotension)
• Airway compromise or stridor
• Failed outpatient management after 48-72 hours
• Suspected deep neck space extension

IV Antibiotic Options:

• Ampicillin-sulbactam: 1.5-3 g IV every 6 hours 8, 9
• Cefuroxime: Standard dosing 9
• Cefotaxime: 2 g IV every 6-8 hours 3

These provide broad-spectrum coverage including streptococci, staphylococci, and anaerobes.

Critical Clinical Pitfalls

1. Do not rely on antibiotics alone: Drainage is essential. Antibiotics without drainage have high failure rates 1.

2. Avoid metronidazole addition: Despite historical practice, the most recent evidence (2023) shows no benefit and increased side effects 6.

3. Staphylococcus aureus resistance: All S. aureus isolates in one study were penicillin-resistant 2. If S. aureus is suspected or cultured, switch to cloxacillin, amoxicillin-clavulanate, or clindamycin.

4. Monitor for treatment failure: If no improvement within 48-72 hours, consider:

   • Inadequate drainage (re-aspirate or perform I&D)
   • Resistant organisms (obtain culture, broaden antibiotics)
   • Deep neck space infection (obtain CT imaging)

Duration and Follow-Up

• Standard duration: 10 days of oral antibiotics 4
• Clinical response expected: Improvement in pain, trismus, and fever within 48-72 hours
• Recurrence rate: Approximately 4-10% with appropriate treatment 5, 9
• Interval tonsillectomy: Consider for recurrent peritonsillar abscess or recurrent tonsillitis, typically performed 4-6 weeks after acute infection resolves

Special Populations

Pediatric patients: Same antibiotic principles apply. Amoxicillin 50 mg/kg/day divided twice daily (max 500 mg/dose) or penicillin V 250 mg three times daily for children 4, 9.